Mark Offerhaus, CEO of Micreos, explains how, for the first time, bad bacteria can be tackled while protecting good bacteria. This has already helped Gladskin help more than 50,000 people.
Mark Offerhaus, CEO of Micreos, explains how, for the first time, bad bacteria can be tackled while protecting good bacteria. This has already helped Gladskin help more than 50,000 people.